MET and hepatocellular carcinoma: Supporting this hypothesis, data from The Cancer Genome Atlas (TCGA) HCC dataset indicate that a subgroup of HCC with high expression of checkpoint genes has a high frequency of amplification of CCND1, FGF19, FGF4, and MET, which are located on the locus 11q13.3 (45).